SCHEMBL6205129

SCHEMBL6205129

CCOCCO[CH]c1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 11/20 0.44
MAPT P10636 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41
THPO P40225 1/20 0.41
NPC1 O15118 1/20 0.41
CHRM5 P08912 1/20 0.41
GRM5 P41594 1/20 0.41
RAB9A P51151 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
RELA Q04206 1/20 0.41
PTGS1 P23219 5/20 0.40
PTGS2 P35354 2/20 0.40
NQO2 P16083 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7563502 0.83 NFE2L2 (0.47) NFE2L2MAPTCYP1A2CYP3A4CYP2D6
SCHEMBL6204519 0.81 ALDH1A1 (0.42) MAPTCYP1A2CYP2D6PKMNPC1
SCHEMBL6204705 0.79 KDM4E (0.49) MAPTCYP1A2CYP3A4CYP2D6MAPK1
SCHEMBL6203484 0.79 ALOX15 (0.49) NFE2L2CYP1A2CHRM5RELANQO2
SCHEMBL8340935 0.79 RELA (0.40) MAPTCYP1A2CYP2D6NPC1RAB9A
SCHEMBL8341640 0.78 RELA (0.39) MAPTCYP1A2CYP2D6NPC1RAB9A
SCHEMBL6204739 0.75 NFE2L2 (0.49) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL7039420 0.71 NFE2L2 (0.58) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL6205337 0.71 CYP11B2 (0.41) MAPTCYP2D6MAPK1NPC1RAB9A
SCHEMBL5244736 0.70 NFE2L2 (0.52) NFE2L2CYP1A2CYP3A4CYP2D6PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1527046-A1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-05-04 EP disclosed
WO-2004009546-A1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-01-29 WO disclosed